Caribou Biosciences (CRBU) Receivables - Other (2020 - 2026)
Caribou Biosciences (CRBU) recorded Receivables - Other of $1.14 million in Q2 2026, down 42.0% from $1.96 million a year earlier and down 21.5% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Receivables - Other (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences reported Receivables - Other of $1.9 million, up 4.2% from FY2024.
- Annual Receivables - Other has a five-year compound annual growth rate of -12.4% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $1.83 million in FY2024 (-20.0%), $2.29 million in FY2023 (+1.7%), $2.25 million in FY2022 (-59.0%) and $5.48 million in FY2021 (+48.9%).
- The Q2 2026 figure is the lowest quarterly Receivables - Other in data going back to Q4 2020.
- On a year-over-year basis, Receivables - Other rose in four of the last eight quarters, with an average decline of 9.9%.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 48.9% in Q4 2021, against a decline of 59.9% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.45 million (Q1 2026), $1.9 million (Q4 2025) and $1.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.12 Bn | 1,134.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.67 Bn | 553.20 Bn | 17.26 Bn |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn |
| 4 | Merck | 377.66 Bn | 332.04 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.82 Bn | 267.81 Bn | 11.24 Bn |
| 6 | Astrazeneca | 266.80 Bn | 240.49 Bn | 12.86 Bn |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.45 Bn | 167.65 Bn | 6.22 Bn |
| 9 | Pfizer | 172.20 Bn | 118.84 Bn | 10.94 Bn |
| 10 | Caribou Biosciences | 53.64 Mn | -462.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 4.17 Mn |
| Dec 31, 2021 | 5.48 Mn |
| Sep 30, 2021 | 5.35 Mn |
API Access
Caribou Biosciences Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();